SLS | Complete SELLAS Life Sciences Group Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
New Stock:Look Up TUESDAY SEP 10 07:57:28pm SLS SELLAS Life Sciences Group, Inc. SCoRE: 62 Learn about the SCoRE PRICE ACTION $1.25 LAST PRICE - AT THE CLOSE SLS is UP18%since the begininning of the year SLS is DOWN-2%BELOW 20 day SMA ...
Sellas Life Sciences股票上涨,该公司的SLS009 CDK9抑制剂被授予FDA罕见儿童疾病认定,用于儿童急性淋巴细胞白血病的治疗,使其有资格进行优先审查... sellas life sciences股票交易上涨,因为该公司获得了FDA罕见儿童疾病认定,用于治疗儿童急性淋巴细胞白血病的SLS009 CDK9抑制剂。 Benzinga06/24 21:22 快讯| Sellas宣布S...
1. SELLAS Life Sciences receives fast track designation from FDA for SLS009 for treatment of relapsed/refractory peripheral T-cell lymphomas. News release. SELLAS Life Sciences. October 30, 2023. Accessed October 30, 2023.https://tinyurl.com/4wt5tetn ...
bodes well for the company in the short term, since they just had the secondary to set some sort of floor to the stock price reply like m but it’s seems to be old news. the interim data is already known. reply like g that's been the pattern even when it ran to 11. reply like...
There’s an E-cell badge on each front wing and the special ‘lumi-electric magno’ mustard-yellow paintjob is memorably lysergic, but other than that it looks like a stock SLS. Doesn't sound like one, though. In fact, it doesn't sound like anything. Standing right beside the E-cell...
I know that's a difficult question to answer but if the stock doubled tomorrow would you not sell? Just trying to see what the end result would be for this companies future. I just went long at 4 today. ReplyLike slapa Investing Group ...
When you determine the value of the stock, most biotech companies also have a bench mark, the funding by large Pharma. The lack of this bench mark today leaves many investors under valuing NeuVax. Dr Ahn responded to this question on market size in the conference stating the Herceptin market...